CrushSCI.com
139.5Average days
121Median days
15Fastest days
432Longest days
512025 publications

Paper Review Records

All Paper Review Records

11 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.

53 days

Molecular characterisation of mixed and dedifferentiated endometrial carcinomas reveals shared pathogenesis and clonal origin

Authors
Judit Betenbuk; Ildikó Vereczkey; Luca Szalai; Andrea Simon; Erika Tóth; Levente Kuthi; Zsombor MeleghShow moreShow less
Affiliations
1. Department of Surgical and Molecular Pathology, Tumor Pathology Center, National Institute of Oncology, Hungary; 2. Department of Pathology and Experimental Cancer Research, Semmelweis University, Hungary; 3. HUN-REN-ONKOL-TTK HCEMM Oncogenomics Research Group, National Institute of Oncology, HungaryShow moreShow less
Source PDF DOI Publisher page
127 days

Prevalence of APC and PTEN Alterations in Urachal Cancer

Authors
Nikolett Nagy; Henning Reis; Boris Hadaschik; Christian Niedworok; Orsolya Módos; Attila Szendrői; Krisztina Bíró; Thomas Hager; Thomas Herold; Jason Ablat; Peter C. Black; Krzysztof Okon; Yuri Tolkach; Anita Csizmarik; Csilla Oláh; David Keresztes; Felix Bremmer; Nadine T. Gaisa; Joerg Kriegsmann; Ilona Kovalszky; András Kiss; József Tímár; Marcell A. Szász; Michael Rink; Margit Fisch; Péter Nyirády; Tibor SzarvasShow moreShow less
Affiliations
1. Department of Urology, Semmelweis University, Budapest, Hungary; 2. Institute of Pathology, West German Cancer Center, University of Duisburg-Essen, University Hospital Essen, Essen, Germany; 3. Department of Urology, West German Cancer Center, University of Duisburg-Essen, University Hospital Essen, Essen, Germany; 4. National Institute of Oncology, Budapest, Hungary; 5. Vancouver Prostate Centre, University of British Columbia, Vancouver, Canada; 6. Department of Pathomorphology, Jagiellonian University, Cracow, Poland; 7. Institute of Pathology, University of Bonn, Bonn, Germany; 8. Institute of Pathology, University of Göttingen, Göttingen, Germany; 9. Institute of Pathology, RWTH Aachen University, Aachen, Germany; 10. Cytology and Molecular Diagnostics Trier, Center for Histology, Trier, Germany; 11. 1st Institute of Pathology and Expreimental Cancer Research, Semmelweis University, Budapest, Hungary; 12. 2nd Department of Pathology, Semmelweis University, Budapest, Hungary; 13. Cancer Center, Semmelweis University, Budapest, Hungary; 14. Department of Urology, University Medical Center Hamburg-Eppendorf, Hamburg, GermanyShow moreShow less
Source PDF DOI Publisher page
15 days

Grade I, II and III Follicular Lymphomas Express Ig V H Genes with Different Patterns of Somatic Mutation

Authors
Balázs Csernus; Botond Timár; Zsolt Fülöp; András MatolcsyShow moreShow less
Affiliations
1. 1st Department of Pathology and Experimental Cancer Research, Faculty of Medicine, Semmelweis University, Budapest, Hungary; 2. Department of Laboratory Medicine, Karolinska Institute, Solna, SwedenShow moreShow less
Source PDF DOI Publisher page
432 days

The Proportion of Tumour-Stroma in Metastatic Lymph Nodes is An Accurately Prognostic Indicator of Poor Survival for Advanced-Stage Colon Cancers

Authors
Mehmet Zengin; Suat BenekShow moreShow less
Affiliations
1. Kırıkkale University, Department of Pathology, Kırıkkale, Turkey; 2. Beylikdüzü State Hospital, Department of General Surgery, Istanbul, TurkeyShow moreShow less
Source PDF DOI Publisher page
40 days

Chromosome X riddle in SARS-CoV-2 (COVID-19) - related lung pathology

Authors
Evangelos Tsiambas; Aristeidis Chrysovergis; Vasileios Papanikolaou; Nicholas Mastronikolis; Vasileios Ragos; Nikolaos Kavantzas; Andreas C. Lazaris; Efstratios Patsouris; Christos Riziotis; Minas Paschopoulos; Efthymios KyrodimosShow moreShow less
Affiliations
1. Department of Cytology, VA Hospital (NIMTS), Athens, Greece; 2. Department of Pathology, Medical School, National and Kapodistrian University of Athens, Athens, Greece; 3. Department of CME, Harvard Medical School, Boston, USA; 4. 1st ENT Department, Hippocration Hospital, National and Kapodistrian, University of Athens, Athens, Greece; 5. Department of Otorhinolaryngology, Head and Neck Surgery, Medical School, University of Patras, Patras, Greece; 6. Department of Maxillofacial Surgery, School of Health Sciences, University of Ioannina, Ioannina, Greece; 7. Theoretical and Physical Chemistry Institute, Photonics for Nanoapplications Laboratory, National Hellenic Research Foundation, Athens, Greece; 8. Department of Obstetrics and Gynaecology, School of Health Sciences, University of Ioannina, Ioannina, GreeceShow moreShow less
Source PDF DOI Publisher page
74 days

Examination of Tumor Regression Grading Systems in Breast Cancer Patients Who Received Neoadjuvant Therapy

Authors
Anita Sejben; Renáta Kószó; Zsuzsanna Kahán; Gábor Cserni; Tamás ZomboriShow moreShow less
Affiliations
1. Department of Pathology, Faculty of Medicine, University of Szeged, Szeged, Hungary; 2. Department of Oncotherapy, University of Szeged, Szeged, Hungary; 3. Department of Pathology, Bács-Kiskun County Teaching Hospital, Kecskemét, HungaryShow moreShow less
Source PDF DOI Publisher page

FAQ

How long does PATHOLOGY & ONCOLOGY RESEARCH take to review a manuscript?

As of 2026-11-19, CrushSCI has 11 complete review records for PATHOLOGY & ONCOLOGY RESEARCH. The fastest paper went from submission to acceptance in 15 days (Grade I, II and III Follicular Lymphomas Express Ig V H Genes with Different Patterns of Somatic Mutation, received 2020-05-26, accepted 2020-06-10); the slowest took 432 days. The average is 139.5 days and the median is 121 days.

Expert Matching · Case Demo

Turn Your Submission Goalsinto a Verifiable Journal Plan

Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.

We will reply within 30 minutes.

CrushSCI online

Client

I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?

CrushSCI

Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.

Suggested title
Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment

SampleLatest 5 valid paper samples from 2026

Average review59.6 days

Median65 days

Contact CrushSCI

Contact CrushSCI

Leave your email address to discuss academic polishing, structural refinement, or one-to-one guidance.

We will reply within 30 minutes.

Selected service: Academic Consulting Service

Leave your email address

Or email us directly at leader@crushsci.com

Enter your email address so we can reply. Your details will remain private.